Pharmaceuticals

Bringing Enhanced Cancer Care to Singapore with Varian's Halcyon System

PALO ALTO, Calif., and SINGAPORE, Sept. 7, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Proton Therapy Pte. Ltd. has placed an order for a Halcyon system, making them the first to bring this innovative treatment platform intoSingapore, with the aim of treating the first patient by...

2020-09-07 07:00 9416

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEORobert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment. The award was given at the 2020 Gender Equality ...

2020-09-04 21:00 3797

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium

SHANGHAI and GAITHERSBURG, Md., Sept. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it has entered into definitive subscription agreeme...

2020-09-04 19:01 11299

AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

NORTH CHICAGO, Illinois and SHANGHAI, China, Sept. 4, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) and I-Mab (Nasdaq: IMAB) announced today that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an inn...

2020-09-04 19:00 10432

111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation

SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, and Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd. ("Baiyunshan Pharmaceutical Sales"), an ...

2020-09-04 18:22 10041

Nippon Express USA Acquires GDP Certification for Chicago Warehouse

TOKYO, Sept. 4, 2020 /PRNewswire/ -- Nippon Express USA, Inc. (hereinafter, "NE USA"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has recently set up NEX Pharma Solutions-Chicago, a temperature-controlled facility specializing in medical and pharmaceutical products, within its ...

2020-09-04 13:00 4741

InxMed Announced the Completion of RMB 130M (~US$ 19M) Series A+ Financing to Accelerate Its Clinical Development and Strengthen Translational Capabilities

NANJING, China, Sept. 4 2020 /PRNewswire/ -- InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced the completion of its Series A+ financing of130M RMB ( ~US$19Mi...

2020-09-04 11:24 3629

Alphamab Oncology announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KN046 for the treatment of thymic epithelial tumor

SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4 bispecific antibody developed by Jiangsu Alphamab Biopharmaceuti...

2020-09-03 23:46 2191

Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis

Not intended for UK and US based media - Company to present 54 abstracts across its MS portfolio - MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence further characterise efficacy and safety of MAVENCLAD® -...

2020-09-03 20:00 3673

Innovent Announces NMPA Granted Marketing Approval for SULINNO® (Adalimumab Injection) in China

SAN FRANCISCO, U.S. and SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...

2020-09-03 17:50 4875

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

COTIGNOLA, Italy, Sept. 3, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1

2020-09-03 00:55 4195

Cambridge Isotope Laboratories, Inc. Expands Benzene and Bromobenzene Capacities to Meet Customer Demands

TEWKSBURY, Massachusetts, Sept. 2, 2020 /PRNewswire/ -- Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotopes and stable isotope-labeled compounds, recently announced a capacity expansion for deuterated benzene at Cambridge Isotope Separations, LLC (CIS), located on 33 ...

2020-09-02 21:00 2908

PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340ks), a biotech company focusing on the development of antibody therapeutics, announcedon August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Dev...

2020-09-02 21:00 1965

Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited

* Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neur...

2020-09-02 20:00 18848

Santalis Partners with iDklic to Bring Customer-Focused Technology to Pharmacies in Europe

SAN FRANCISCO, Sept. 2, 2020 /PRNewswire/ -- iDklic, leaders in scaled digital marketing solutions for retail pharmacies acrossEurope, today announced an agreement with pharmaceutical company Santalis to deploy consumer experience-focused digital solutions in more than 90 pharmacies inBelgium in ...

2020-09-02 19:00 2358

Harbour BioMed Presented Its Newly Discovered Anti-Human CCR8 Novel Monoclonal Antibodies at the 16th PEGS Boston 2020

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, Sept. 2, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company, presented its newly discovered novel anti-human CCR8 mAbs (HBM1022) at the 16th PEGS Boston Summit. HBM1022 was designed...

2020-09-02 11:40 3896

3SBio MSCI ESG Rating Upgraded to A, Ranking at the Forefront of the Global Biotechnology Industry

SHANGHAI, Sept. 2, 2020 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings forAugust 26th 2020, 3SBio has been upgraded to A status, surpassing that of 78% of companies in the global biotechnology industry. MSCI ESG ratings focus on ESG issues th...

2020-09-02 02:15 10272

Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia

Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization SAN DIEGO and ADELAIDE, Australia, Sept. 2, 2020 /PRNewswire/ -- The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation today announ...

2020-09-02 01:01 5166

Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK

HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus") , Mr. Rani Jarkas, is invited to speak at the"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th November 2020. This year, the event will be ...

2020-09-01 09:00 4971

Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody

SAN FRANCISCO, and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2020-09-01 08:00 2405
1 ... 281282283284285286287 ... 313

Week's Top Stories